Pharmacological Signatures of the Exenatide Nanoparticles Complex Against Myocardial Ischemia Reperfusion Injury

Conclusion: The block copolymer PLL-PEG-PLL may function as a potent exenatide nanocarrier for augmenting pharmacotherapy against MI/RI with unprecedented clinical benefits. Further study is needed to better clarify the underlying mechanisms.Kidney Blood Press Res 2018;43:1273 –1284
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research